Ion Beam Applications SA (EBR:IBAB)

Ion Beam Applications Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	638.98	620.18	498.16	466.67	361.27	312.96
Revenue Growth	3.03%	24.49%	6.75%	29.17%	15.43%	0.32%
Gross Profit Gross Profit Growth	218.52	199.62	168.09	134.44	126.77	107.69
Operating Income Operating Income Growth	40.23	34.73	28.1	7.61	9.45	13.67
Net Income Net Income Growth	24.63	12.73	9.25	-9.11	6.06	3.88
Earnings Per Share EPS Growth	0.85	0.42	0.31	-0.31	0.20	0.13
EPS Growth	101.65%	33.94%	-	-	56.07%	-88.03%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
IBA Technologies IBA Technologies Growth	236.46	224.86	223.53	-	-	-
Clinical Proton Therapy Clinical Proton Therapy Growth	-	334.34	212.83	-	-	-
IBA Clinical - Dosimetry IBA Clinical - Dosimetry Growth	-	65.69	65.88	65.91	53.97	52.33
Eliminations Eliminations Growth	-	-4.72	-4.09	-3.62	-1.53	-
Total Total Growth	639.08	620.18	498.16	466.67	361.27	312.96

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	-	65.25	72.59	109.62	169.5	199.27
Total Debt Total Debt Growth	-	116.89	43.69	41.58	40.87	68.98
Net Cash (Debt) Net Cash Growth	-	-51.64	28.89	68.03	128.64	130.29
Net Cash Growth	-	-	-57.53%	-47.11%	-1.27%	92.22%
Net Cash Per Share Net Cash Per Share Growth	-	-1.70	0.98	2.34	4.26	4.32

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-	-25.67	-10.59	-19.77	21.71	87.21
Capital Expenditures CapEx Growth	-	-9.32	-4.28	-5.27	-3.23	-4.25
Free Cash Flow Free Cash Flow Growth	-	-34.99	-14.87	-25.03	18.48	82.97
Free Cash Flow Growth	-	-	-	-	-77.72%	-15.23%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	34.20%	32.19%	33.74%	28.81%	35.09%	34.41%
Operating Margin	6.30%	5.60%	5.64%	1.63%	2.62%	4.37%
Pretax Margin	4.67%	3.03%	2.99%	-0.07%	-0.12%	2.64%
Profit Margin	3.85%	2.05%	1.86%	-1.95%	1.68%	1.24%
FCF Margin	-	-5.64%	-2.99%	-5.36%	5.12%	26.51%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.250	0.250	0.240	0.170	0.210	0.190
Dividend Per Share Growth	4.17%	4.17%	41.18%	-19.05%	10.53%	-5.00%
Dividend Yield	1.59%	1.96%	1.83%	1.52%	1.41%	1.31%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	19.87	29.70	42.32	-	74.89	114.02
Forward PE	20.86	8.54	15.77	65.94	35.16	76.20
P/FCF Ratio	-	-	-	-	24.55	5.33
PS Ratio	0.77	0.61	0.79	0.72	1.26	1.41

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 31, 2026

Data Sources Report a data error